4 Jun 2015 18:53

Pharmstandard majority shareholders boost stake to 60.72%

MOSCOW. June 4 (Interfax) - The main shareholders in Pharmstandard, Viktor Kharitonin and Yegor Kulkov have closed a deal to purchase 6.4% of shares in the pharmaceutical producer from Alexander Shuster.

Bristley Enterprises Limited, the company through which Shuster owns share in Pharmstandard, sold 2.42 million shares on May 18, the company said in materials.

Augment Investments, whose beneficiaries are Kharitonin and Kulkov, reached agreement with Shuster on sale of the 2.42 million shares for $22 each (a total of $53.24 million) in mid-May. Prior to the deal, Augment owned 54.32% of shares. In other words, the acquisition boosted Augment's stake to 60.72%.